FDA Regulation for Misleading Drugs
A new initiative by the U.S. Food and Drug Administration (FDA) is reshaping the landscape of pharmaceutical advertising. In response to growing concerns over misleading drug commercials, the FDA has begun tightening its regulation of direct-to-consumer (DTC) pharmaceutical marketing. These ads, known for their upbeat music, radiant actors, and flawless lifestyles, have long dominated American television. They are also a major profit engine for both drug manufacturers and broadcasting...
